Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 70,000 shares at $19.52 ($1.4M) on 2025-09-04, disclosed to the SEC on 2025-09-05.
Open-market sale of $1.4M CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.08 | 20,000 | $402K | 28.9% |
| 2 | $20.08 | 20,000 | $402K | 28.9% |
| 3 | $19.52 | 30,000 | $586K | 42.2% |
| Total | $19.84 avg | 70,000 | $1.4M | 100% |
| Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |
| CPRX | SELL | 2024-03-28 | $822K | — | Filing → |